AstraZeneca PLC (ZEGA) — Capital Reinvestment Ratio
Latest as of September 2025:
0.34x
AstraZeneca PLC (ZEGA) has a Capital Reinvestment Ratio of 0.34x as of September 2025, meaning it reinvests 0% of its operating cash flow (€5.13 Billion) in capital expenditures (€1.73 Billion). See free cash flow generation of AstraZeneca PLC to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.34x
Capex / Operating Cash Flow
Operating Cash Flow
€5.13 Billion
EUR
Capital Expenditures
€1.73 Billion
EUR
Data as of
Sep 2025
Most recent filing
AstraZeneca PLC Capital Reinvestment Ratio (2014–2024)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (2014–2024)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 2014 to 2024. For live market cap and broader valuation context, see market cap of AstraZeneca PLC.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | €11.86 Billion | €4.59 Billion | ▲ +18.3% |
| 2023 | 0.33x | €10.36 Billion | €3.39 Billion | ▲ +193.7% |
| 2022 | 0.11x | €9.81 Billion | €1.09 Billion | ▼ -39.2% |
| 2021 | 0.18x | €5.96 Billion | €1.09 Billion | ▼ -8.6% |
| 2020 | 0.20x | €4.80 Billion | €961.00 Million | ▼ -39.3% |
| 2019 | 0.33x | €2.97 Billion | €979.00 Million | ▼ -17.2% |
| 2018 | 0.40x | €2.62 Billion | €1.04 Billion | ▲ +7.5% |
| 2017 | 0.37x | €3.58 Billion | €1.33 Billion | ▼ -33.6% |
| 2016 | 0.56x | €4.14 Billion | €2.31 Billion | ▲ +39.7% |
| 2015 | 0.40x | €3.32 Billion | €1.33 Billion | ▲ +178.6% |
| 2014 | 0.14x | €7.06 Billion | €1.01 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow